Mediolanum International Funds’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.8M Sell
94,540
-30,590
-24% -$6.34M 0.16% 149
2026
Q1
$27.5M Buy
125,130
+4,735
+4% +$1.18M 0.29% 86
2025
Q4
$29.3M Buy
120,395
+54,260
+82% +$13.9M 0.29% 76
2025
Q3
$17.9M Buy
66,135
+8,474
+15% +$2.31M 0.19% 125
2025
Q2
$14.7M Buy
57,661
+11,664
+25% +$2.78M 0.18% 145
2025
Q1
$10.1M Buy
45,997
+14,985
+48% +$3.5M 0.14% 168
2024
Q4
$7.1M Buy
31,012
+19,893
+179% +$4.79M 0.09% 196
2024
Q3
$2.65M Sell
11,119
-529
-5% -$118K 0.04% 307
2024
Q2
$2.08M Buy
11,648
+210
+2% +$42.6K 0.03% 294
2024
Q1
$2.25M Buy
+11,438
New +$2.1M 0.04% 290

Other funds holding RMD

Mediolanum International Funds's RMD Position: Q2 2026 in Review

Mediolanum International Funds reduced its ResMed (RMD) stake by 24% in Q2 2026, selling an estimated $6.34M and leaving 94,540 shares worth $18.8M. The position accounts for 0.16% of the portfolio, ranked #149.

Mediolanum International Funds first reported a position in RMD in Q1 2024 and has held it in 10 quarters since. The position peaked at $29.3M in Q4 2025. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Mediolanum International Funds held 94,540 shares of ResMed worth $18.8M as of Q2 2026.
  • Mediolanum International Funds sold 30,590 ResMed shares in Q2 2026, an estimated $6.34M.
  • ResMed made up 0.16% of Mediolanum International Funds's portfolio in Q2 2026, its #149 holding.
  • Mediolanum International Funds first reported a position in ResMed in Q1 2024 and has held it in 10 quarters since.
  • Mediolanum International Funds's ResMed position peaked at $29.3M in Q4 2025.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Mediolanum International Funds's 13F filing for Q2 2026, filed 23 Jul 2026.